Effect of high protein on cvd risk factors and inflammation in obese childre
Not Applicable
- Conditions
- overweight and obesity.ovweight and obesity in children
- Registration Number
- IRCT201307232839N6
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
inclusion criteria: if they had not known kidney, liver, cardiovascular, allergy, respiratory, thyroid diseases and diabetes; did not taken medications.
exclusion criteria: if they did not followed their prescribed diet; had hypercholesterolemia and hypertension.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Aiponectin. Timepoint: week 0 and 10. Method of measurement: biochemical tests.;Hs-CRP. Timepoint: week 0 and 10. Method of measurement: biochemical tests.;Tumor necrosis factor alpha. Timepoint: week 0 and 10. Method of measurement: biochemical tests.;Interlukine 6. Timepoint: week 0 and 10. Method of measurement: biochemical tests.
- Secondary Outcome Measures
Name Time Method Anthropometric measurements. Timepoint: week 0 and 10. Method of measurement: meter, scale.;LDL cholesterol. Timepoint: week 0 and 10. Method of measurement: biochemical tets.;HDL cholesterol. Timepoint: week 0 and 10. Method of measurement: biochemical tets.;Total cholesterol. Timepoint: week 0 and 10. Method of measurement: biochemical tets.;Triglyceride. Timepoint: week 0 and 10. Method of measurement: biochemical tets.;Fasting blood glucose. Timepoint: week 0 and 10. Method of measurement: biochemical tets.;Blood pressure. Timepoint: week 0 and 10. Method of measurement: kaff.;Fasting blood insulin. Timepoint: week 0 and 10. Method of measurement: biochemical tets.